Mice were treated with ketoconazole with and without dimethyl sulfoxide. Concentrations of ketoconazole at 3 and 5 h after treatment were significantly higher in serum (P < 0.05) and brain tissue homogenate (P < 0.01) of mice treated with dimethyl sulfoxide than in those of mice not treated with dimethyl sulfoxide.
KTZ per g of brain tissue and up to 40 ,ug of KTZ per ml of serum. The concentrations of KTZ in serum and BTH were determined from the standard curves. The amount of blood within the brain was determined by the method of Lowry and Hastings (14) . * Corresponding author.
Differences observed in the concentrations of KTZ in serum and BTH between DMSO-treated and untreated mice were analyzed by using the Wilcoxon signed-rank test (6) . A P value of >0.05 was not considered significant.
To determine whether DMSO interfered with the antifungal activity of KTZ in the bioassay, various concentrations of KTZ and DMSO were combined and added to the serum and BTH. Identical concentrations of only KTZ in the serum and BTH were assayed at the same time. No significant differences were seen in the diameters of zones of inhibition with comparable concentrations of KTZ with and without DMSO.
The results showed that the concentrations of KTZ in the BTH and serum of DMSO-treated mice were consistently higher when compared with those of mice not treated with DMSO at each time interval (Table 1 ). The highest concentration of KTZ in both the BTH (11.8 ,ug/g) and serum (46.6 ,ug/ml) was achieved at 3 h after treatment of mice receiving DMSO. This is a statistically significant increase over the concentration of KTZ at 3 h in BTH (P < 0.01) and serum (P < 0.05) in mice not treated with DMSO. Although the concentration of KTZ decreased at 5 h whether DMSO was given or not, mice given DMSO still had a significantly higher concentration of KTZ in both BTH (P < 0.01) and serum (P < 0.01) than did mice not receiving DMSO.
A 9.8% mortality rate as a result of toxicity was observed in DMSO-treated mice, with no difference seen between KTZ-treated and untreated mice. No mice died that were treated only with KTZ. Immediately after intravenous inoculation with DMSO, a temporary paralysis of the hind legs was observed. Hematuria began on about day 2 of treatment but disappeared after DMSO treatment was discontinued. The cause of death was usually seizures that developed immediately following intravenous inoculation.
Of particular interest was the high concentration of KTZ maintained in the serum (12.9 [Lg/ml) and BTH (6.7 ,ug/g) as long as 5 h after treatment with KTZ and DMSO. The concentration of KTZ in BTH exceeds the MIC required for in vitro inhibition of fungi such as Cryptococcus neoformans which commonly invade the brain. It might appear that the higher concentrations of KTZ in BTH in DMSO-treated mice reflects the higher concentration of KTZ in the serum. However, the insignificant amount of blood (0.1 ,ug/g of tissue) present in BTH suggests that increased permeability of the BBB may be important in increasing the concentration of KTZ. Attempts to penetrate the BBB with a variety of compounds by using DMSO have met with varied levels of success (2, 9, 15, 17) . Broadwell et al. (4) showed that ANTIMICROB. AGENTS CHEMOTHER. Because uninfected animals were used in this study, the antifungal effect of KTZ after enhancement with DMSO in an infected host is not known. It is possible that the pharmacokinetics of KTZ is altered by DMSO, causing it to be inactive against fungi in the host, although this was not seen in vitro. Also, the toxicity of the 15% concentration of DMSO must be addressed, since this would not be acceptable for human use. Because 10% concentrations of DMSO reduced toxicity considerably in experimental animals (5), it will be interesting to determine whether a 10% DMSO concentration in combination with KTZ will result in a significant survival rate in a murine model of cryptococcosis (12) .
